KalVista Pharmaceuticals, Inc. (KALV) Insider Trading

Over the last 3 months, KALV insiders made 0 open-market buys and 23 sales, a net sale of -$5.9M (SEC Form 4). Over the last 6 months, 132 institutions increased and 94 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
23
Net (3m)
-$5.9M
Insider trades by month Buys Sells
Nov
Dec
Feb
Mar
Apr
May
Context3-month price +64.6%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
May 29, 2026Yea Christopherofficer: CHIEF DEVELOPMENT OFFICERSell33,800$26.78
May 29, 2026Yea Christopherofficer: CHIEF DEVELOPMENT OFFICEROption33,800$7.07
May 27, 2026Yea Christopherofficer: CHIEF DEVELOPMENT OFFICEROption3,125
May 27, 2026Sweeny Nicoleofficer: Chief Commercial OfficerOption5,000
May 27, 2026Yea Christopherofficer: CHIEF DEVELOPMENT OFFICERSell1,966$26.78
May 27, 2026Sweeny Nicoleofficer: Chief Commercial OfficerSell1,489$26.78
May 27, 2026Audhya Paul K.officer: CHIEF MEDICAL OFFICEROption5,000
May 27, 2026Audhya Paul K.officer: CHIEF MEDICAL OFFICERSell2,239$26.78
May 26, 2026Piekos Brianofficer: Chief Financial OfficerSell1,489$26.78
May 26, 2026Audhya Paul K.officer: CHIEF MEDICAL OFFICERSell2,685$26.78
May 26, 2026Audhya Paul K.officer: CHIEF MEDICAL OFFICEROption6,250
May 26, 2026Yea Christopherofficer: CHIEF DEVELOPMENT OFFICERSell2,358$26.78
May 26, 2026Palleiko Benjamin Ldirector, officer: CHIEF EXECUTIVE OFFICEROption23,250
May 26, 2026Palleiko Benjamin Ldirector, officer: CHIEF EXECUTIVE OFFICERSell10,926$26.78
May 26, 2026Yea Christopherofficer: CHIEF DEVELOPMENT OFFICEROption3,750
May 26, 2026Sweeny Nicoleofficer: Chief Commercial OfficerSell1,861$26.78
May 26, 2026Piekos Brianofficer: Chief Financial OfficerOption5,000
May 26, 2026Sweeny Nicoleofficer: Chief Commercial OfficerOption6,250
May 19, 2026Audhya Paul K.officer: CHIEF MEDICAL OFFICEROption2,419
May 19, 2026Yea Christopherofficer: CHIEF DEVELOPMENT OFFICERSell1,108$26.76
May 19, 2026Palleiko Benjamin Ldirector, officer: CHIEF EXECUTIVE OFFICEROption2,419
May 19, 2026Palleiko Benjamin Ldirector, officer: CHIEF EXECUTIVE OFFICERSell1,129$26.76
May 19, 2026Yea Christopherofficer: CHIEF DEVELOPMENT OFFICEROption1,774
May 19, 2026Audhya Paul K.officer: CHIEF MEDICAL OFFICERSell1,032$26.76
May 13, 2026Palleiko Benjamin Ldirector, officer: CHIEF EXECUTIVE OFFICEROption7,120
May 13, 2026Palleiko Benjamin Ldirector, officer: CHIEF EXECUTIVE OFFICERSell3,322$26.71
Apr 20, 2026Piekos Brianofficer: Chief Financial OfficerOption6,250
Apr 20, 2026Sweeny Nicoleofficer: Chief Commercial OfficerSell1,862$20.22
Apr 20, 2026Audhya Paul K.officer: CHIEF MEDICAL OFFICERSell2,686$20.22
Apr 20, 2026Palleiko Benjamin Ldirector, officer: CHIEF EXECUTIVE OFFICEROption20,312

Source: KALV SEC Form 4 filings, latest May 29, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their KALV positions over the last 6 months (SEC Form 13F).

Increased
132
New positions
68
Reduced
94
Sold out
36
Largest moves
InstitutionActionSharesFiled
VR ADVISER, LLCUnchanged6.7MFeb 17, 2026
VR ADVISER, LLCReduced6.5MMay 15, 2026
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.Unchanged5.0MFeb 13, 2026
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.Reduced5.0MMay 15, 2026
SUVRETTA CAPITAL MANAGEMENT, LLCUnchanged4.8MMay 15, 2026
SUVRETTA CAPITAL MANAGEMENT, LLCUnchanged4.8MFeb 17, 2026
TANG CAPITAL MANAGEMENT LLCReduced4.6MFeb 17, 2026
TANG CAPITAL MANAGEMENT LLCUnchanged4.6MMay 15, 2026
BLACKROCK, INC.Increased3.8MMay 13, 2026
BLACKROCK, INC.Increased3.8MFeb 12, 2026
MILLENNIUM MANAGEMENT LLCIncreased2.9MFeb 17, 2026
SILVERARC CAPITAL MANAGEMENT, LLCIncreased2.9MMay 14, 2026
CAPITAL WORLD INVESTORSUnchanged2.8MMay 13, 2026
CAPITAL WORLD INVESTORSReduced2.8MFeb 11, 2026
VANGUARD GROUP INCIncreased2.5MJan 29, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.